Evidence of proatherogenic inflammation in polycystic ovary syndrome

Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis, Endocr Rev, 18, 774, 10.1210/er.18.6.774 Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern Unites States: a prospective study, J Clin Endocrinol Metab, 83, 3078, 10.1210/jc.83.9.3078 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Hum Reprod, 19, 41, 10.1093/humrep/deh098 Goodarzi, 2002, The importance of insulin resistance in polycystic ovary syndrome, Fertil Steril, 77, 255 Burghen, 1980, Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease, J Clin Endocrinol Metab, 50, 113, 10.1210/jcem-50-1-113 Nestler, 1998, Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, J Clin Endocrinol Metab, 83, 2001, 10.1210/jc.83.6.2001 Nigro, 2006, Insulin resistance and atherosclerosis, Endocr Rev, 27, 242, 10.1210/er.2005-0007 Christian, 2003, Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 88, 2562, 10.1210/jc.2003-030334 Talbott, 2004, Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome, J Clin Endocrinol Metab, 89, 5454, 10.1210/jc.2003-032237 NIH, NHLBI, 1998, Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults—the evidence report, Obesity Res, 6, 51S Colditz, 1995, Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med, 122, 481, 10.7326/0003-4819-122-7-199504010-00001 Vgontzas, 2006, Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea, Metabolism, 55, 1076, 10.1016/j.metabol.2006.04.002 Diamanti-Kandarakis, 2006, Inflammatory and endothelial markers in women with polycystic ovary syndrome, Eur J Clin Invest, 36, 691, 10.1111/j.1365-2362.2006.01712.x Hu, 2006, Monocyte chemoattractant protein–1 and its correlation with lipoprotein in polycystic ovary syndrome, Beijing Da Xue Xue Bao, 38, 487 Boulman, 2004, Increased C-reactive protean levels in the polycystic ovary syndrome: a marker of cardiovascular disease, J Clin Endocrinol Metab, 89, 2160, 10.1210/jc.2003-031096 Lewandowski, 2006, Increased circulating levels of matrix metalloproteinase–2 and –9 in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 1173, 10.1210/jc.2005-0648 Orio, 2004, Is plasminogen activator inhibitor–1 a cardiovascular risk factor in young women with polycystic ovary syndrome?, Reprod Biomed Online, 9, 505, 10.1016/S1472-6483(10)61634-3 Ibanez, 2004, Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity, J Clin Endocrinol Metab, 89, 1592, 10.1210/jc.2003-031281 Morin-Papunen, 2003, Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 88, 4649, 10.1210/jc.2002-021688 Evans, 2002, Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr Rev, 23, 599, 10.1210/er.2001-0039 Mohanty, 2000, Glucose challenge stimulates reactive oxygen species generation by leucocytes, J Clin Endocrinol Metab, 85, 2970, 10.1210/jc.85.8.2970 Barnes, 1997, Nuclear factor–κB: a pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506 González, 2006, Reactive oxygen species–induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 336, 10.1210/jc.2005-1696 González, 2006, Increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 1508, 10.1210/jc.2005-2327 Romano, 1997, Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment, Immunity, 6, 315, 10.1016/S1074-7613(00)80334-9 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Heinrich, 1991, Interleukin-6 and the acute phase response, Biochem J, 265, 621, 10.1042/bj2650621 Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202 Zwaka, 2001, C-reactive protein–mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis, Circulation, 103, 1194, 10.1161/01.CIR.103.9.1194 Vaughan, 1883, PAI-1 and atherothrombosis, J Thromb Haemost, 3, 1879, 10.1111/j.1538-7836.2005.01420.x Newby, 2005, Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture, Physiol Res, 85, 1, 10.1152/physrev.00048.2003 González, 2005, Hyperglycemia alters tumor necrosis factor–α release from mononuclear cells in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 5336, 10.1210/jc.2005-0694 2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Modan, 1989, Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples, Diabetes, 38, 1630, 10.2337/diabetes.38.12.1630 Matthews, 1885, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Kohrt, 1993, Insulin resistance of aging is related to abdominal obesity, Diabetes, 42, 273, 10.2337/diabetes.42.2.273 Taylor, 1998, Body mass index, waist girth, and waist to hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves, Am J Clin Nutr, 67, 44, 10.1093/ajcn/67.1.44 Andrews, 1991, A rapid micropreparation technique for extraction of DNA-binding proteins from limited numbers of mammalian cells, Nucleic Acids Res, 19, 2499, 10.1093/nar/19.9.2499 González, 2006, Altered tumor necrosis factor–α release from mononuclear cells of obese reproductive-age women during hyperglycemia, Metabolism, 55, 271, 10.1016/j.metabol.2005.08.022 Kirwan, 2001, Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia, Am J Physiol Endocrinol Metab, 281, E1137, 10.1152/ajpendo.2001.281.6.E1137 Kirchengast, 2001, Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome, Hum Reprod, 16, 1255, 10.1093/humrep/16.6.1255 Ibanez, 2004, Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity, Hum Reprod, 19, 1725, 10.1093/humrep/deh329 Yildirim, 2003, Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome, Fertil Steril, 79, 1358, 10.1016/S0015-0282(03)00265-6 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 Fain, 2004, Comparison of the release of adiponectin by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans, Endocrinol, 145, 2273, 10.1210/en.2003-1336 González, 2006, In vitro evidence that hyperglycemia stimulates tumor necrosis factor–α release in obese women with polycystic ovary syndrome, J Endocrinol, 188, 521, 10.1677/joe.1.06579 McCrohon, 1999, Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular adhesion molecule–1, Circulation, 99, 2317, 10.1161/01.CIR.99.17.2317 Zhu, 1997, 17β-Estradiol, progesterone and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages, Am J Obstet Gynecol, 177, 196, 10.1016/S0002-9378(97)70462-9 Adams, 1995, Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness, Arterioscler Thromb Vasc Biol, 15, 562, 10.1161/01.ATV.15.5.562